NFATc1 Is Required for Vitamin D- and Phosphate-Mediated Regulation of Osteocyte Lacuno-Canalicular Remodeling
Endocrinology · 2024
DOI: 10.1210/endocr/bqae087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2024. Verfasst von Supriya Jagga und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Bone Remodeling, Fibroblast Growth Factor-23, NFATC Transcription Factors, Osteocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institutes of Health, Brigham and Women's Hospital.
Abstract (Originalsprache)
Osteocytes are embedded in lacunae and connected by canaliculi (lacuno-canalicular network, LCN). Bones from mice with X-linked hypophosphatemia (Hyp), which have impaired production of 1,25 dihydroxyvitamin D (1,25D) and hypophosphatemia, have abnormal LCN structure that is improved by treatment with 1,25D or an anti-FGF23 targeting antibody, supporting roles for 1,25D and phosphate in regulating LCN remodeling. Bones from mice lacking the vitamin D receptor (VDR) in osteocytes (Vdrf/f;Dmp1Cre+) and mice lacking the sodium phosphate transporter 2a (Npt2aKO), which have low serum phosphate with high serum 1,25D, have impaired LCN organization, demonstrating that osteocyte-specific actions of 1,25D and hypophosphatemia regulate LCN remodeling. In osteoclasts, nuclear factor of activated T cells cytoplasmic 1 (NFATc1) is critical for stimulating bone resorption. Since osteocytes also resorb matrix, we hypothesize that NFATc1 plays a role in 1,25D and phosphate-mediated LCN remodeling. Consistent with this, 1,25D and phosphate suppress Nfatc1 mRNA expression in IDG-SW3 osteocytes, and knockdown of Nfatc1 expression in IDG-SW3 cells blocks 1,25D- and phosphate-mediated suppression of matrix resorption gene expression and 1,25D- and phosphate-mediated suppression of RANKL-induced acidification of the osteocyte microenvironment. To determine the role of NFATc1 in 1,25D- and phosphate-mediated LCN remodeling in vivo, histomorphometric analyses of tibiae from mice lacking osteocyte-specific Nfatc1 in Vdrf/f;Dmp1Cre+ and Npt2aKO mice were performed, demonstrating that bones from these mice have decreased lacunar size and expression of matrix resorption genes, and improved canalicular structure compared to Vdrf/f;Dmp1Cre+ and Npt2aKO control. This study demonstrates that NFATc1 is necessary for 1,25D- and phosphate-mediated regulation of LCN remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Boston, MA 02115, USA.
- Harvard Medical School, Boston, MA 02115, USA.
- Endocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
- Department of Translational Dental Medicine, Boston University School of Dental Medicine, Boston, MA 02118, USA.
ORCID-Profile: Eva S Liu
Förderung
- NIAMS NIH HHS
- National Institutes of Health
- Brigham and Women's Hospital
Zitieren
APA
Jagga, S., Hughes, A., Manoochehri Arash, N., Sorsby, M., Brooks, D. J., Divieti Pajevic, P., & Liu, E. S. (2024). NFATc1 Is Required for Vitamin D- and Phosphate-Mediated Regulation of Osteocyte Lacuno-Canalicular Remodeling. Endocrinology. https://doi.org/10.1210/endocr/bqae087
Vancouver
Jagga S, Hughes A, Manoochehri Arash N, Sorsby M, Brooks DJ, Divieti Pajevic P, et al. NFATc1 Is Required for Vitamin D- and Phosphate-Mediated Regulation of Osteocyte Lacuno-Canalicular Remodeling. Endocrinology. 2024. doi:10.1210/endocr/bqae087
BibTeX
@article{Jagga2024,
author = {Jagga, Supriya and Hughes, Ashleigh and Manoochehri Arash, Niusha and Sorsby, Melissa and Brooks, Daniel J and Divieti Pajevic, Paola and Liu, Eva S},
title = {NFATc1 Is Required for Vitamin D- and Phosphate-Mediated Regulation of Osteocyte Lacuno-Canalicular Remodeling},
journal = {Endocrinology},
year = {2024},
doi = {10.1210/endocr/bqae087}
}
EUVIMED